Business Description
Orion Oyj
ISIN : FI0009014377
Share Class Description:
MIL:1ORNBV: Class BDescription
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.63 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.33 | |||||
| Debt-to-EBITDA | 0.79 | |||||
| Interest Coverage | 115.72 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 10.42 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14 | |||||
| 3-Year EBITDA Growth Rate | 12.9 | |||||
| 3-Year EPS without NRI Growth Rate | 20.1 | |||||
| 3-Year FCF Growth Rate | 16.5 | |||||
| 3-Year Book Growth Rate | 10.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 17.67 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 10.03 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 99.74 | |||||
| 14-Day RSI | 97.62 | |||||
| 3-1 Month Momentum % | -8.82 | |||||
| 6-1 Month Momentum % | -6.85 | |||||
| 12-1 Month Momentum % | 15.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.72 | |||||
| Quick Ratio | 2.19 | |||||
| Cash Ratio | 0.75 | |||||
| Days Inventory | 237.67 | |||||
| Days Sales Outstanding | 54.35 | |||||
| Days Payable | 54.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.12 | |||||
| Dividend Payout Ratio | 0.69 | |||||
| 3-Year Dividend Growth Rate | 2.6 | |||||
| Forward Dividend Yield % | 3.16 | |||||
| 5-Year Yield-on-Cost % | 3.39 | |||||
| Shareholder Yield % | 2.29 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.36 | |||||
| Operating Margin % | 27.01 | |||||
| Net Margin % | 21.39 | |||||
| FCF Margin % | 13.39 | |||||
| ROE % | 38.47 | |||||
| ROA % | 21.73 | |||||
| ROIC % | 26.59 | |||||
| 3-Year ROIIC % | 26.81 | |||||
| ROC (Joel Greenblatt) % | 58.96 | |||||
| ROCE % | 35.75 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.86 | |||||
| Forward PE Ratio | 22.79 | |||||
| PE Ratio without NRI | 22.86 | |||||
| Shiller PE Ratio | 26.19 | |||||
| Price-to-Owner-Earnings | 40.26 | |||||
| PEG Ratio | 5.58 | |||||
| PS Ratio | 4.89 | |||||
| PB Ratio | 7.48 | |||||
| Price-to-Tangible-Book | 9.06 | |||||
| Price-to-Free-Cash-Flow | 36.44 | |||||
| Price-to-Operating-Cash-Flow | 25.68 | |||||
| EV-to-EBIT | 18.51 | |||||
| EV-to-Forward-EBIT | 22.64 | |||||
| EV-to-EBITDA | 18.51 | |||||
| EV-to-Forward-EBITDA | 19.4 | |||||
| EV-to-Revenue | 5 | |||||
| EV-to-Forward-Revenue | 4.82 | |||||
| EV-to-FCF | 37.34 | |||||
| Price-to-GF-Value | 0.96 | |||||
| Price-to-Projected-FCF | 2.5 | |||||
| Price-to-Median-PS-Value | 1.03 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.7 | |||||
| Price-to-Graham-Number | 3.03 | |||||
| Price-to-Net-Current-Asset-Value | 19.15 | |||||
| Earnings Yield (Greenblatt) % | 5.4 | |||||
| FCF Yield % | 2.72 | |||||
| Forward Rate of Return (Yacktman) % | 8.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orion Oyj Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,542.5 | ||
| EPS (TTM) (€) | 2.34 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 33.97 | ||
| 14-Day RSI | 97.62 | ||
| 14-Day ATR (€) | 0.448835 | ||
| 20-Day SMA (€) | 46.8 | ||
| 12-1 Month Momentum % | 15.43 | ||
| 52-Week Range (€) | 34.67 - 53.54 | ||
| Shares Outstanding (Mil) | 140.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orion Oyj Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orion Oyj Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Orion Oyj Frequently Asked Questions
What is Orion Oyj(MIL:1ORNBV)'s stock price today?
The current price of MIL:1ORNBV is €51.90. The 52 week high of MIL:1ORNBV is €53.54 and 52 week low is €34.67.
When is next earnings date of Orion Oyj(MIL:1ORNBV)?
The next earnings date of Orion Oyj(MIL:1ORNBV) is 2025-04-23.
Does Orion Oyj(MIL:1ORNBV) pay dividends? If so, how much?
The Dividend Yield %  of Orion Oyj(MIL:1ORNBV) is 3.12% (As of Today), Highest Dividend Payout Ratio of Orion Oyj(MIL:1ORNBV) was 1.11. The lowest was 0.6. And the median was 0.92. The  Forward Dividend Yield % of Orion Oyj(MIL:1ORNBV) is 3.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers